Abstract
Spasticity is the result of increased muscle tone, and there are many causes. Nurses that care for patients who have spasticity will find the detailed pathophysiology, excellent clinical examples, and evidence-based treatment modalities very helpful. There are two interesting patient examples, demonstrating opposite views on the challenges parents go through in trying to decide what is best for their children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott R (1999) Selective dorsal rhizotomy. http://cerebnet.netfirms.com/selective.htm. Retrieved 16 Aug 2005
Adams M, Hicks AL (2010) Spasticity; pathophysiology, assessment, and management. In: Lin VW (ed) Spinal cord medicine: principles and practice. Demos Medical Publishing, New York
Albright AL, Ferson SS (2006) Intrathecal baclofen therapy in children. Neurosurg Focus 21(2):1–6
Atiyeh BS, Hayek SN, Skaf GS, Araj AA, Chamoun RB (2006) Baclofen pump pocket infection: a case report of successful salvage with muscle flap. Int Wound J 3:23–28
Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R (2003) Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol 18:26–34
Bergenheim AT, Wendelius M, Shahidi S, Larsson E (2003) Spasticity in a child with myelomeningocele treated with continuous intrathecal Baclofen. Pediatr Neurosurg 39:218–221. doi:10.1159/000072476
Boviatsis EJ, Kouyialis AT, Boutsikakis I, Korfas S, Sakas DE (2004) Infected CNS infusion pumps: is there a chance for treatment without removal? Acta Neurochir 146:463–467
Center for Disease Control and Prevention, (1999) Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 20(4):250–278
Cheek WR (1996) Atlas of pediatric neurosurgery. W.B. Saunders Company, Philadelphia
Dario A, Tomei G (2004) A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 27(11):799–818
Dario A, Scamoni C, Picano M, Fortini G, Cuffari A, Tomei G (2005) The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation 8(1):36–39
Dawes WJ, Drake JM, Fehlings D (2003) Microfracture of a baclofen pump catheter with intermittent under- and overdose. Pediatr Neurosurg 39(3):144–148
Dietz V (2000) Spastic movement disorder. Spinal Cord 38:389–393
Douglas AF, Weiner HL, Schwartz DR (2005) Prolonged intrathecal baclofen withdrawal syndrome. J Neurosurg 102:1133–1136
Fitzgerald JJ, Tsegaye M, Vloeberghs MH (2004) Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases. Br J Neurosurg 18(3):240–245
Follett KA, Burchiel K, Deer T, Dupen S, Prager J, Turner MS et al (2003) Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation 6(1):32–41
Gallichio JE (2004) Pharmacologic management of spasticity following stroke. Phys Ther 84(10):973–981
Goldstein EM (2001) Spasticity management: an overview. J Child Neurol 16(1):16–23
Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML (2003) Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 39:1–6
Grunt S, Becher JG, Vermeulen RJ (2011) Long-term Âoutcome and adverse effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review. Dev Med Child Neurol 53:490–498. doi:10.1111/j.469-8749.2011.03912.x
Guettard E, Roze E, Abada G, Lemesle C, Vidailhet M, Laurent-Vannier A et al (2009) Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A. Dev Neurorehabil 12(3):128–138. doi:10.1080/17518420902927994
Hesselgard K, Reinstrup P, Stromblad LG, Unden J, Romner B (2005) Selective dorsal rhizotomy and postoperative pain management. Pediatr Neurosurg 43:107–112. doi:10.1159/000098382
Institute for Neurology and Neurosurgery (2004) Rhizotomy. http://nyneruosurgery.org/cp/thizhist.html. Retrieved 16 Aug 2005
Keenan E (2010) Spasticity management, part 3: surgery and the use of intrathecal baclofen. Br J Neurosci Nurs 6(1):12–18
Koman LA, Smith B, Balkrishnan R (2003) Spasticity associated with cerebral palsy in children. Paediatr Drugs 5(1):11–23
Krach LE (2001) Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J Child Neurol 16(1):31–36
Krach LE, Kriel R, Day SM, Strauss DJ (2010) Survival of individual with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study. Dev Med Child Neurol 52:672–676. doi:10.1111/j.1469-8749.2009.03473.x
MacWilliam BA, Johnson BA, Shuckra AL, D’Astous JL (2011) Functional decline in children undergoing selective dorsal rhizotomy after age 10. Dev Med Child Neurol 53:717–723. doi:10.1111/j.1469-8749.2011.04010.x
Mohammed I, Hussain A (2004) Intrathecal baclofen withdrwal sysndrome – a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol 4(6):1–5. doi:10.1186/1472-6904-4-6
Morton RE, Gray N, Vloeberghs M (2011) Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy. Dev Med Child Neurol 53:736–741. doi:10.1111/j1469-8749.2011.04009.x
Moss SD, Manwaring KH (1992) Relief of spasticity for children with cerebral palsy using selective posterior rhizotomy. Phoenix Child Hosp Pediatr Rev 4(1):5–11
Motta F, Buonaguro V, Stignani C (2007) The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 107:32–35. doi:10.3171/PED-07/07/032
Mullarkey T (2009) Considerations in the treatment of spasticity with intrathecal baclofen. Am J Health Syst Pharm 66(Suppl 5):s14–s22. doi:10.2146/ajhp0108c
O’Donnell M, Armstrong R (1997) Pharmacologic interventions for management of spasticity in cerebral palsy. Ment Retard Dev Disabil Res Rev 3:204–211
Ou C, Kent S, Miller S, Steinbok P (2010) Selective dorsal rhizotomy in children: comparison of outcomes after single-level versus multi-level laminectomy technique. Can J Neurosci Nurs 32(3):17–24
Plassat R, Verbe BP, Menei P, Menegalli D, Mathe JF, Richard I (2004) Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42:686–693
Priori A, Cogiamanian F, Mrakic-Sposta S (2006) Pathophysiology of spasticity. Neurol Sci Supp 4(27):s307–s309. doi:10.1007/s10072-006-0647-2
Ramstad K, Jahnsen R, Lofterod B, Skjeldal OH (2010) Continuous intrathecal baclofen therapy in children with cerebral palsy – when does improvement emerge? Acta Paediatr 99:1661–1665. doi:10.1111/j.1651-2227.2009.01596x
Ridley B, Rawlins PK (2006) Intrathecal baclofen therapy: ten steps toward best practice. J Neurosci Nurs 38(2):72–82
Rizzo MA, Hadjimichael OC, Preinigherova J, Vollmer TL (2004) Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 10:589–595
Roscigno CI (2002) Addressing spasticity-related pain in children with spastic cerebral palsy. J Neurosci Nurs 34(3):123–133
Satkunam LE (2003) Rehabilitation medicine: 3. Management of adult spasticity. CMAJ 169(11):1173–1179
Sheean G (2002) The pathophysiology of spasticity. Eur J Neurol 9(Suppl 1):3–9
Stallings VA, Cronk CE, Zemel BS, Charney EB (1995) Body composition in children with spastic quadriplegic cerebral palsy. J Pediatr 126:833–839
Steinbok P (2006) Selection of treatment modalities in children with spastic cerebral palsy. Neurosurg Focus 21(2):1–8. doi:10.317/foc.2006.21.2.5
Thompson AJ, Jarrett L, Lockley L, Marsden J, Stevenson VL (2005) Clinical management of spasticity. J Neurol Neurosurg Psychiatry 76:459–463. doi:10.1136/jnnp.2004.035972
Tedroff K, Lowing K, Jacobson DN, Astrom E (2011) Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy. Dev Med Child Neurol 53(8):724–729. doi:10.1111/j1469-8749.2011.03909x Epud 18 May 2011
Vanek ZF, Menkes JH, Carcione J, Talavera F, Lopate G, Benbadis S, Berman SA (2010) Spasticity. eMedicine Neurol. http://www.emedicine.com/neuro/topic706.htm. Retrieved 21 Jan 2004
Vender LR, Hester S, Rekito A, Lee MR (2005) Baclofen intrathecal pump delivery systems, avoidance and management of complications in adult and pediatric patients: part 2. Contemp Neurosurg 27(2):1–5
Vitztum C, Olney B (2000) Intrathecal baclofen therapy and the child with cerebral palsy. Orthop Nurs 19(1):43–48
Von Koch CS, Park TS, Steinbok P, Smyth M, Peacock WJ (2001) Selective posterior rhizotomy and intrathecal baclofen for the treatment of spasticity. Pediatr Neurosurg 35:57–65
Ward AB, Molenaers G, Colosimo C, Berardelli A (2006) Clinical value of botulinum toxin in neurological indications. Eur J Neurol 13(Suppl 4):20–26
Ward A, Hayden S, Dexter M, Scheinberg A (2009) Continuous intrathecal baclofen for children with spasticity and/or dystonia: goal attainment and complications associated with treatment. J Paediatr Child Health 45:720–726. doi:10.1111/j.1440-1754.2009.01601.x
Wong V (2003) Evidence-based approach of the use of botulinum toxin type A (BTX) in cerebral palsy. Pediatr Rehabil 6(2):85–96. doi:10.1080/1363849031000139306
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Yu, H. (2013). Surgical Management of Spasticity. In: Cartwright, C., Wallace, D. (eds) Nursing Care of the Pediatric Neurosurgery Patient. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-32554-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-32554-0_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-32553-3
Online ISBN: 978-3-642-32554-0
eBook Packages: MedicineMedicine (R0)